Author tools & resources | Elsevier
Whatever stage you are at in your publication journey, Elsevier has resources to make your tasks easier.
Related Articles
CAR T-Cell Therapy in Multiple Myeloma: Clinical Data and Patient Selection
A panel of experts on multiple myeloma discuss the role of CAR T-cell therapy in the evolving treatment landscape, highlighting clinical trial data, recent approvals,…
The Evolving Role of ctDNA in Guiding Adjuvant Chemotherapy Decisions in CRC: Insights from Stacey A. Cohen, MD
Stacey A. Cohen, MD, discusses insights into the evolving role of circulating tumor DNA in clinical decision-making for patients with colorectal cancer.
Phase III CheckMate 77T Study | IASLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the FDA approval of perioperative nivolumab based on the Phase…
FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injecti
FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injection
6-Year Data Sustain Adjuvant Olaparib Benefit in BRCA1/2+, HER2- Breast Cancer
Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast cancer, according to 6-year data from the OlympiA…
Celebrating a year of immunotherapy/cell and gene therapy in Blood Advances
With the close of 2024, we wanted to take stock of the eighth year for Blood Advances, which had another banner year. We continue to…
An ALPINE guide to covalent BTKis in CLL
In this issue of Blood, Brown et al1 present the final comparative analysis of the ALPINE study, comparing zanubrutinib with ibrutinib for patients with re
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
